Statements (53)
Predicate | Object |
---|---|
gptkbp:instanceOf |
mental disorder
|
gptkbp:affects |
adolescents
adults children (rarely) |
gptkbp:alsoKnownAs |
bipolar disorder
manic-depressive illness |
gptkbp:canBeManagedBy |
long-term treatment
|
gptkbp:cause |
occupational difficulties
impaired social functioning increased risk of suicide |
gptkbp:characterizedBy |
episodes of depression
episodes of mania |
gptkbp:comorbidity |
ADHD
eating disorders substance use disorders anxiety disorders |
gptkbp:diagnosedBy |
psychiatric evaluation
|
gptkbp:DSM-5_code |
296.x
|
gptkbp:firstDescribed |
gptkb:Emil_Kraepelin
|
gptkbp:hasBiologicalBasis |
neurotransmitter imbalance
brain structure abnormalities |
gptkbp:hasGeneticComponent |
yes
|
https://www.w3.org/2000/01/rdf-schema#label |
Bipolar affective disorder
|
gptkbp:ICD-10_code |
gptkb:F31
|
gptkbp:offersCourse |
episodic
chronic |
gptkbp:onset |
usually late adolescence or early adulthood
|
gptkbp:prevalence |
about 1% of the population
|
gptkbp:prognosis |
variable
|
gptkbp:riskFactor |
substance abuse
family history of bipolar disorder high stress |
gptkbp:subspecies |
gptkb:Bipolar_II_disorder
gptkb:Bipolar_I_disorder gptkb:Cyclothymic_disorder |
gptkbp:symptom |
mood swings
fatigue suicidal thoughts irritability decreased need for sleep elevated mood feelings of sadness increased activity loss of interest |
gptkbp:treatment |
gptkb:psychotherapy
antipsychotic medications mood stabilizers antidepressants |
gptkbp:triggeredBy |
substance use
sleep deprivation stressful life events |
gptkbp:bfsParent |
gptkb:F31
|
gptkbp:bfsLayer |
5
|